JP2015522077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522077A5 JP2015522077A5 JP2015521792A JP2015521792A JP2015522077A5 JP 2015522077 A5 JP2015522077 A5 JP 2015522077A5 JP 2015521792 A JP2015521792 A JP 2015521792A JP 2015521792 A JP2015521792 A JP 2015521792A JP 2015522077 A5 JP2015522077 A5 JP 2015522077A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- fampridine
- laquinimod
- pharmaceutical composition
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670758P | 2012-07-12 | 2012-07-12 | |
| US61/670,758 | 2012-07-12 | ||
| PCT/US2013/050001 WO2014011827A1 (en) | 2012-07-12 | 2013-07-11 | Treatment of multiple sclerosis with combination of laquinimod and fampridine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015522077A JP2015522077A (ja) | 2015-08-03 |
| JP2015522077A5 true JP2015522077A5 (enExample) | 2016-09-01 |
Family
ID=49914160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015521792A Pending JP2015522077A (ja) | 2012-07-12 | 2013-07-11 | ラキニモドおよびファムプリジンの組合せによる多発性硬化症の治療 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140017226A1 (enExample) |
| EP (1) | EP2872217A4 (enExample) |
| JP (1) | JP2015522077A (enExample) |
| KR (1) | KR20150038072A (enExample) |
| CN (1) | CN104582793A (enExample) |
| AR (1) | AR091724A1 (enExample) |
| AU (1) | AU2013290181A1 (enExample) |
| BR (1) | BR112015000616A2 (enExample) |
| CA (1) | CA2873229A1 (enExample) |
| EA (1) | EA201590191A1 (enExample) |
| HK (1) | HK1209672A1 (enExample) |
| IL (1) | IL236230A0 (enExample) |
| MX (1) | MX2015000485A (enExample) |
| PY (1) | PY1330684A (enExample) |
| TW (1) | TW201408300A (enExample) |
| UY (1) | UY34896A (enExample) |
| WO (1) | WO2014011827A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR089862A1 (es) | 2012-02-03 | 2014-09-24 | Teva Pharma | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA |
| MX2014009889A (es) | 2012-02-16 | 2014-11-13 | Teva Pharma | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinoli ncarboxamida, preparacion y usos de los mismos. |
| TW201410244A (zh) | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療ｇａｂａ媒介之疾病之拉喹莫德（ｌａｑｕｉｎｉｍｏｄ） |
| MX2015005632A (es) | 2012-11-07 | 2016-02-05 | Teva Pharma | Sales de amina de laquinimod. |
| EP2970129A2 (en) | 2013-03-14 | 2016-01-20 | Teva Pharmaceutical Industries Ltd. | Crystals of laquinimod sodium and improved process for the manufacture thereof |
| KR20170005434A (ko) * | 2014-04-29 | 2017-01-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 높은 장애 상태를 갖는 재발-완화형 다발성 경화증(rrms) 환자 치료용 라퀴니모드 |
| GB2540163A (en) * | 2015-07-07 | 2017-01-11 | Univ London Queen Mary | Combination therapy for treating multiple sclerosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726339D0 (en) * | 1997-12-13 | 1998-02-11 | Zeneca Ltd | Human-derived tissue-specific potassium channel |
| US20090082471A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched fingolimod |
| ES2329327B1 (es) * | 2008-03-19 | 2010-09-17 | Proyecto De Biomedicina Cima, S.L. | Combinaciones sinergicas de 5'-metiltioadenosina. |
| CL2009001841A1 (es) * | 2008-09-10 | 2011-02-18 | Acorda Therapeutics Inc | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. |
| EP2442651B1 (en) * | 2009-06-19 | 2015-07-29 | Teva Pharmaceutical Industries Ltd. | Treatment of multiple sclerosis with laquinimod |
| EP2766020A4 (en) * | 2011-10-12 | 2015-04-01 | Teva Pharma | TREATMENT OF MULTIPLE SCLEROSIS BY COMBINING LAQUINIMOD AND FINGOLIMOD |
-
2013
- 2013-07-09 UY UY0001034896A patent/UY34896A/es not_active Application Discontinuation
- 2013-07-10 AR ARP130102454 patent/AR091724A1/es unknown
- 2013-07-10 PY PY201301330684A patent/PY1330684A/es unknown
- 2013-07-10 TW TW102124792A patent/TW201408300A/zh unknown
- 2013-07-11 EA EA201590191A patent/EA201590191A1/ru unknown
- 2013-07-11 BR BR112015000616A patent/BR112015000616A2/pt not_active IP Right Cessation
- 2013-07-11 HK HK15110240.0A patent/HK1209672A1/xx unknown
- 2013-07-11 US US13/939,306 patent/US20140017226A1/en not_active Abandoned
- 2013-07-11 WO PCT/US2013/050001 patent/WO2014011827A1/en not_active Ceased
- 2013-07-11 JP JP2015521792A patent/JP2015522077A/ja active Pending
- 2013-07-11 MX MX2015000485A patent/MX2015000485A/es unknown
- 2013-07-11 KR KR1020157003858A patent/KR20150038072A/ko not_active Withdrawn
- 2013-07-11 CN CN201380037036.0A patent/CN104582793A/zh active Pending
- 2013-07-11 EP EP13816075.9A patent/EP2872217A4/en not_active Withdrawn
- 2013-07-11 AU AU2013290181A patent/AU2013290181A1/en not_active Abandoned
- 2013-07-11 CA CA2873229A patent/CA2873229A1/en not_active Abandoned
-
2014
- 2014-12-14 IL IL236230A patent/IL236230A0/en unknown
-
2016
- 2016-04-21 US US15/135,280 patent/US20160235735A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2015512406A5 (enExample) | ||
| JP2010518122A5 (enExample) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2017510607A5 (enExample) | ||
| JP2017510607A (ja) | Ｓ１ｐ調節剤即時放出投与レジメン | |
| JP2016510343A5 (enExample) | ||
| JP2020500864A5 (enExample) | ||
| JP2019023195A (ja) | Ｌ−４−クロロキヌレニンの剤形及び治療的使用 | |
| KR20170128633A (ko) | 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도 | |
| JP2016505050A5 (enExample) | ||
| JP2015522077A (ja) | ラキニモドおよびファムプリジンの組合せによる多発性硬化症の治療 | |
| US20050282879A1 (en) | Methods and composition for treatment of migraine and symptoms thereof | |
| JP6885649B2 (ja) | 統合失調症の治療のためのイロペリドン | |
| JPH03170475A (ja) | 抑うつ症治療剤 | |
| JP2023531930A5 (enExample) | ||
| US20200360303A1 (en) | Method for treating hyperhidrosis | |
| JP2015515971A5 (enExample) | ||
| KR101978459B1 (ko) | 조루증 치료용 약학 조성물 및 조루증 치료 방법 | |
| JP2016533323A5 (enExample) | ||
| EP2767287B1 (en) | Agent for preventing or treating htlv-i associated myelopathy | |
| WO2007000967A1 (ja) | 脳梗塞治療薬 | |
| Ratchford | Dementia, HIV-associated | |
| JP2013537232A5 (enExample) |